Christian Bryant

Join Dr. Christian Bryant, a consultant haematologist from RPA in Sydney with a PhD focused on myeloma immunology, as he delves into the complex world of multiple myeloma treatment. He discusses the intriguing phenomenon of chromothripsis and its implications on disease progression. Dr. Bryant also highlights the revolutionary CAR-T therapy and explores strategies for personalized treatment. The significance of minimal residual disease (MRD) assessment emerges as a vital topic, painting a hopeful picture for future breakthroughs in myeloma management.